Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Parkinson's Disease

Free Subscription 06.04.2026 2 BMC Neurol 1 Brain Res 1 Exp Neurol 2 J Neural Transm (Vienna) 1 J Neurosci 4 Mov Disord 1 Neurol Clin Pract 1 Neurosci Lett 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. DAGHI M, Serhier Z, Lakhdar A, El Otmani H, et al
   Alignment of 5-2-1 criteria with Neurologists' clinical judgment in identifying Advanced Parkinson's Disease in Morocco: A cross-sectional inter-rater agreement study.
   BMC Neurol. 2026 Mar 27. doi: 10.1186/s12883-026-04817.
   PubMed        
   
   
2. NILUFER BP, Demet Y, Melih A, Betul A, et al
   Olfactory dysfunction in essential tremor with rest tremor: a cross-sectional comparison with parkinson's disease and essential tremor.
   BMC Neurol. 2026 Mar 28. doi: 10.1186/s12883-026-04864.
   PubMed        
   
   

   
   Brain Res

3. PARTHIBAN A, Thippeswamy NP, Jayanthi PA, Palaniselvam S, et al
   Synergistic effect of carboxymethyl chitosan and phloroglucinol against rotenone induced Parkinson's disease in zebrafish model.
   Brain Res. 2026;1882:150284.
   PubMed         Abstract available
   
   

   
   Exp Neurol

4. LIU T, Zhang M, Wei J
   Does ACE2 deficiency have a role in Parkinson's disease -exacerbated pulmonary fibrosis?
   Exp Neurol. 2026;401:115744.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

5. BARBOSA PM, Parmera JB, Warner TT
   Correction: Neuropathology in genetic Parkinson's disease: a focused review of pathological and clinical findings.
   J Neural Transm (Vienna). 2026 Mar 31. doi: 10.1007/s00702-026-03136.
   PubMed        
   
   
6. RODRIGUEZ-ANTIGUEDAD J, Bojtos L, Kulisevsky J
   A narrative review of clinical and non-clinical determinants of health-related quality of life in advanced Parkinson's disease.
   J Neural Transm (Vienna). 2026 Mar 31. doi: 10.1007/s00702-026-03142.
   PubMed         Abstract available
   
   

   
   J Neurosci

7. LUTHRA NS, Bonham LW, Moreno AJ, Park C, et al
   Longevity factor klotho and resistance to cognitive deficits in individuals with Parkinson's disease and in an alpha-synuclein mouse model.
   J Neurosci. 2026 Mar 31:e1904252026. doi: 10.1523/JNEUROSCI.1904-25.2026.
   PubMed         Abstract available
   
   

   
   Mov Disord

8. SHEN R, Meng Z, Zhu X, Lyu H, et al
   Divergent Glymphatic Dysfunction and Free Water Pathology Underpin Distinct Mechanisms and Enable Differential Diagnosis in Parkinson's Disease and Multiple System Atrophy.
   Mov Disord. 2026 Apr 2. doi: 10.1002/mds.70293.
   PubMed         Abstract available
   
   
9. KOEGLSPERGER T, Scherer M, Kuhn AA, Eusebio A, et al
   Adaptive Deep Brain Stimulation for Parkinson's Disease: Navigating the Roadblocks to Clinical Implementation.
   Mov Disord. 2026 Apr 1. doi: 10.1002/mds.70284.
   PubMed         Abstract available
   
   
10. LEENTJENS AFG, Pontone GM
    Perspective: Depression in Persons with Parkinson's Disease.
    Mov Disord. 2026 Mar 31. doi: 10.1002/mds.70285.
    PubMed         Abstract available
    
    
11. SANTINELLI L, Pratuseviciute N, Lange LM, Kleinz T, et al
    Lack of Cerebrospinal Fluid alpha-Synuclein Seeding in VPS35 D620N- and LRRK2 Y1699C-Linked Parkinson's Disease.
    Mov Disord. 2026 Mar 30. doi: 10.1002/mds.70291.
    PubMed        
    
    

    
    Neurol Clin Pract

12. HEY GE, Kamo H, Perez Rodriguez Garcia G, Mehta TR, et al
    Long-Term Outcomes of Subthalamic Nucleus and Globus Pallidus Interna Deep Brain Stimulation for Young-Onset Parkinson Disease.
    Neurol Clin Pract. 2026;16:e200605.
    PubMed         Abstract available
    
    

    
    Neurosci Lett

13. SWAIN C, Pokharel D, Peshattiwar V, Le K, et al
    Effects of chronic levodopa in the paraquat and lectin rat model of the "body-first" subtype of Parkinson's disease.
    Neurosci Lett. 2026 Apr 1:138596. doi: 10.1016/j.neulet.2026.138596.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

14. MOON JS, Moutusy SI, Zhang M, Ndayisaba A, et al
    Cytotoxic T cell recognition of alpha-synuclein drives pathogenic immune responses in multiple system atrophy.
    Proc Natl Acad Sci U S A. 2026;123:e2537271123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum